Literature DB >> 24890849

The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.

K Louvanto1, J Rautava, K Syrjänen, S Grénman, S Syrjänen.   

Abstract

Persistence of high-risk (HR-) human papillomavirus (HPV) infection of the uterine cervix increases the risk of cervical cancer. Oral HPV infections are among potential covariates of long-term genotype-specific persistent cervical HR-HPV infections. It is not known whether this persistence reflects inability of the host to reject HPV infections in general. A case-control setting was designed to estimate the covariates of long-term persistent cervical HR-HPV infections using multivariate generalized estimating equation (GEE) models. HPV was detected with PCR using GP05+/GP06+-primers and genotyped for 24 HPVs with a Multimetrix-kit. The cases (n=43) included women who had genotype-specific persistent cervical HR-HPV infection for at least 24 months (24M+) and controls were women who tested repeatedly HPV-negative in their cervical samples (n=52). These women represent a sub-cohort of the Finnish Family HPV Study. The cases differed significantly from the HPV-negative controls in several aspects: they were younger, had a longer mean time to incident oral HPV infection (40.7 versus 23.6 months), longer duration of oral HPV persistence (38.4 versus 14.1 months), and longer time to clearance of their oral HPV infection (50.0 versus 28.2 months). In multivariate GEE analysis, the second pregnancy during the follow up was the only independent predictor with significant protective effect against 24M+ persistent cervical HR-HPV infections, OR of 0.15 (95% CI 0.07-0.34). To conclude, long-term persistent cervical HR-HPV infections are associated with a prolonged clearance of oral HR-HPV infections while new pregnancy protects against persistent cervical HR-HPV infections.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Cervical infections; high-risk human papillomavirus; oral human papillomavirus; persistence; pregnancy; risk factors

Mesh:

Year:  2014        PMID: 24890849     DOI: 10.1111/1469-0691.12700

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

Review 1.  The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.

Authors:  Theresa Guo; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2016-05-06       Impact factor: 6.860

2.  Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study.

Authors:  Christine M Pierce Campbell; Aimée R Kreimer; Hui-Yi Lin; William Fulp; Michael T O'Keefe; Donna J Ingles; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-09

3.  The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.

Authors:  Laura L Reimers; Supriya D Mehta; L Stewart Massad; Robert D Burk; Xianhong Xie; Jacques Ravel; Mardge H Cohen; Joel M Palefsky; Kathleen M Weber; Xiaonan Xue; Kathryn Anastos; Howard Minkoff; Jessica Atrio; Gypsyamber D'Souza; Qian Ye; Christine Colie; Christine P Zolnik; Gregory T Spear; Howard D Strickler
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

4.  Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years.

Authors:  Anna Paaso; Hanna-Mari Koskimaa; Marij Jp Welters; Seija Grénman; Kari Syrjänen; Sjoerd H van der Burg; Stina Syrjänen
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

Review 5.  The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature.

Authors:  Sylvia Taylor; Eveline Bunge; Marina Bakker; Xavier Castellsagué
Journal:  BMC Infect Dis       Date:  2016-06-14       Impact factor: 3.090

Review 6.  Oral manifestations of human papillomavirus infections.

Authors:  Stina Syrjänen
Journal:  Eur J Oral Sci       Date:  2018-10       Impact factor: 2.612

7.  Low Rates of Dual-Site and Concordant Oral-Cervical Human Papillomavirus Infections and Cancers: A Systematic Review.

Authors:  Kelsey H Jordan; Chloe M Beverly Hery; Xiaochen Zhang; Electra D Paskett
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.